Back to 
BNP Paribas Financial Markets
BNP Paribas Financial Markets
CLDX
Showing 8 of 29 quarters
Position history for BNP Paribas Financial Markets's holdings in Celldex Therapeutics, Inc.
Yes. BNP Paribas Financial Markets holds 31,191 shares of CLDX (Celldex Therapeutics), worth $1.2M, as of its Q2 2026 13F filing. It reduced the position by 144,597 shares (-82.3%) from Q1 2026. BNP Paribas Financial Markets has held CLDX since Q2 2019, across 29 quarterly 13F filings.
Current Value
$1.2M
Current Shares
31,191
Total Value Change
+$202,745
Total Shares Change
+3,010
Quarter-by-Quarter History